http://www.blacklistednews.com/news-10613-0-6-6--.html
The swine flu just happened to be sold as a World wide pandemic and they tried to make it mandatory for all of us to have to take it.
Every country's government bought and distributed this poison without question to it's unsuspecting population.
A global decision made by a global government.....specifically called The World Health Organization or the W.H.O.
Source: Organic Health Adviser
Would you feel comfortable being injected with a vaccine that contains a substance that has been strongly linked to infertility? Well, if you take the Fluarix swine flu vaccine manufactured by GlaxoSmithKline or any of the other swine flu vaccines that contain Polysorbate 80 that is exactly what you will be doing. If you are considering getting the swine flu vaccine, or any other vaccine for that matter, perhaps you should educate yourself about EXACTLY what is in these vaccines before you allow them to be injected into your body.
Perhaps you think that linking the swine flu vaccine with infertility is quite a stretch. Well, let's take this one step at a time.
#1) Polysorbate 80 is in the Fluarix swine flu vaccine manufactured by GlaxoSmithKline according to the CDC. This is confirmed by the CDC in the document below.....
http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf
#2) A medical study done in Slovakia injected newborn female rats with Tween 80 (Polysorbate 80). These newborn female rats were injected with Polysorbate 80 at days 4 to 7 after birth. The researchers found that Polysorbate 80 accelerated the maturation of the female rats, damaged the vagina and womb lining, caused significant hormonal changes, severe ovary deformities and ultimately rendered the young female rats infertile.
In fact, Dee Nicholson, the National Communications Director for Freedom in Canadian Health Care is not shy about saying that Polysorbate 80 is "linked to infertility in mice".
#3) In the package insert for Fluarix, GlaxoSmithKline specifically mentions that they cannot guarantee that their flu vaccine will not damage your fertility: "FLUARIX has not been evaluated for carcinogenic or mutagenic potential, or for impairment of fertility." Thanks to foolishly passed laws by the U.S. government, you will not be able to sue anyone if it does leave you infertile.
#4) GlaxoSmithKline is not alone in using Polysorbate 80. It is being reported that Novartis is using the adjuvant MF59 in its swine flu vaccine. The MF59 adjuvant contains Tween80 (Polysorbate 80) and squalene among other things.
#5) On the World Intellectual Property Organization, a patent application for a "fertility impairing vaccine". The University of Georgia Research Foundation is listed as the patent applicant.
In the description section of the patent application, Tween 80 (Polysorbate 80) is listed as a preferred ingredient:
"In a preferred embodiment the vaccine comprises oil, preferably a biodegradable oil such as squalene oil, in an amount of about 2.5% to about 15%, preferably about 8% to about 12%. In preparing the vaccine it is advantageous to combine a concentrated oily adjuvant composition with an aqueous solution of the antigen, pZP glycoprotein. Typically, the vaccine is prepared using an adjuvant concentrate which contains lecithin (about 5% to about 15 % wt/vol, preferably about 12% wt/vol) and STDCM (preferably about 25 mg/mL to about 50 mg/mL) in squalene oil. The term % wt/vol means grams per 100 mL of liquid. The aqueous solution containing the isolated pZP glycoprotein is typically a phosphate-buffered saline (PBS) solution, and additionally preferably contains Tween 80 (about 0.2% vol/vol to about 0.8% vol/vol, preferably about 0.4% vol/vol)."
#6) The United Nations is actively seeking ways to limit and control population growth around the globe. An incredibly shocking U.N. population division policy brief from March 2009 asked this very disturbing question:
What would it take to accelerate fertility decline in the least developed countries?
You can read this almost unbelievable document here:
http://www.un.org/esa/population/publications/UNPD_policybriefs/UNPD_policy_brief1.pdf
The reality is that for the super wealthy global elite and the majority of the social engineers at the United Nations, population control is a major obsession. If you doubt this fact, just read this article:
http://signsofthelastdays.com/archives/the-radical-population-control-and-eugenics-agenda-of-the-global-elite
The truth is that the more people learn about what is in these vaccines, the less likely they are to take them. It is important to do your own research before letting anyone inject anything into your body. Those who blindly trust the government or world health authorities are likely the ones to end up being extremely disappointed in the end.
Showing posts with label GlaxoSmithKline. Show all posts
Showing posts with label GlaxoSmithKline. Show all posts
Monday, September 20, 2010
Friday, June 4, 2010
Report condemns swine flu experts' ties to big pharma
http://www.guardian.co.uk/business/2010/jun/04/swine-flu-experts-big-pharmaceutical
The end results of a conflict of interest.
World wide taxpayer rape
Trio of scientists who urged stockpiling had previously been paid, says report
Scientists who drew up the key World Health Organisation guidelines advising governments to stockpile drugs in the event of a flu pandemic had previously been paid by drug companies which stood to profit, according to a report out today.
An investigation by the British Medical Journal and the Bureau of Investigative Journalism, the not-for-profit reporting unit, shows that WHO guidance issued in 2004 was authored by three scientists who had previously received payment for other work from Roche, which makes Tamiflu, and GlaxoSmithKline (GSK), manufacturer of Relenza.
City analysts say that pharmaceutical companies banked more than $7bn (£4.8bn) as governments stockpiled drugs. The issue of transparency has risen to the forefront of public health debate after dramatic predictions last year about a swine flu pandemic did not come true.
The end results of a conflict of interest.
World wide taxpayer rape
Trio of scientists who urged stockpiling had previously been paid, says report
Scientists who drew up the key World Health Organisation guidelines advising governments to stockpile drugs in the event of a flu pandemic had previously been paid by drug companies which stood to profit, according to a report out today.
An investigation by the British Medical Journal and the Bureau of Investigative Journalism, the not-for-profit reporting unit, shows that WHO guidance issued in 2004 was authored by three scientists who had previously received payment for other work from Roche, which makes Tamiflu, and GlaxoSmithKline (GSK), manufacturer of Relenza.
City analysts say that pharmaceutical companies banked more than $7bn (£4.8bn) as governments stockpiled drugs. The issue of transparency has risen to the forefront of public health debate after dramatic predictions last year about a swine flu pandemic did not come true.
Thursday, October 15, 2009
antidepressant Paxil to blame for baby's heart defects
--------------------------------------------------------------------------------
http://www.telegraph.co.uk/health/he...ury-rules.html
A prime example of why "The Mother's law" should not be allowed to come into effect.
A US family has been awarded $2.5 million (£1.6 million) in damages after a Philadelphia jury decided that the antidepressant Paxil, known as Seroxat in Britain, was responsible for their son's birth defects.
GlaxoSmithKline Plc, the British manufacturer of Seroxat, said it would appeal against the verdict in the case, which is the first of 600 such cases to come to trial.
http://www.telegraph.co.uk/health/he...ury-rules.html
A prime example of why "The Mother's law" should not be allowed to come into effect.
A US family has been awarded $2.5 million (£1.6 million) in damages after a Philadelphia jury decided that the antidepressant Paxil, known as Seroxat in Britain, was responsible for their son's birth defects.
GlaxoSmithKline Plc, the British manufacturer of Seroxat, said it would appeal against the verdict in the case, which is the first of 600 such cases to come to trial.
Sunday, August 2, 2009
Glaxo Adds Masks to Flu Franchise, Boosting Sales From Pandemic
http://www.bloomberg.com/apps/news?p...d=aWGa_HZqay1o
July 31 (Bloomberg) -- GlaxoSmithKline Plc may reap 1.53 billion pounds ($2.52 billion) of sales from the outbreak of pandemic flu in the next six months, and that’s before the drugmaker introduces its latest influenza product.
Glaxo makes Relenza, the second-biggest-selling drug for people who have caught swine flu, and is developing a vaccine to prevent the spread of the bug. The sales forecast from Royal Bank of Scotland Plc doesn’t take into account the company’s newest venture: A mask to shield wearers from the virus.
While it’s too early to estimate potential sales of the masks, Relenza and the swine flu vaccine might bring in 1.53 billion pounds over the next six months, said Michael Leacock, an analyst at RBS in London. Roche Holding AG, by contrast, forecasts sales of 1.39 billion Swiss francs ($1.28 billion) for its Tamiflu antiviral drug. Novartis AG’s swine flu vaccine will likely bring in $290 million, while Sanofi-Aventis SA’s own shot will generate $270 million, Credit Suisse Group AG estimates.
“Glaxo is one of the best-positioned companies to respond to and benefit from increasing demand for pandemic and seasonal flu products,” Jeffrey
July 31 (Bloomberg) -- GlaxoSmithKline Plc may reap 1.53 billion pounds ($2.52 billion) of sales from the outbreak of pandemic flu in the next six months, and that’s before the drugmaker introduces its latest influenza product.
Glaxo makes Relenza, the second-biggest-selling drug for people who have caught swine flu, and is developing a vaccine to prevent the spread of the bug. The sales forecast from Royal Bank of Scotland Plc doesn’t take into account the company’s newest venture: A mask to shield wearers from the virus.
While it’s too early to estimate potential sales of the masks, Relenza and the swine flu vaccine might bring in 1.53 billion pounds over the next six months, said Michael Leacock, an analyst at RBS in London. Roche Holding AG, by contrast, forecasts sales of 1.39 billion Swiss francs ($1.28 billion) for its Tamiflu antiviral drug. Novartis AG’s swine flu vaccine will likely bring in $290 million, while Sanofi-Aventis SA’s own shot will generate $270 million, Credit Suisse Group AG estimates.
“Glaxo is one of the best-positioned companies to respond to and benefit from increasing demand for pandemic and seasonal flu products,” Jeffrey
Saturday, July 25, 2009
Squalene: The Swine Flu Vaccine’s Dirty Little Secret Exposed
http://blogs.mercola.com/sites/vitalvotes/archive/2009/07/17/Squalene-The-Swine-Flu-Vaccines-Dirty-Little-Secret-Exposed.aspx
And as if Vaccines Weren’t Dangerous Enough on Their Own …
… imagine them turbocharged.
The main ingredient in a vaccine is either killed viruses or live ones that have been attenuated (weakened and made less harmful).
Flu vaccines can also contain a number of chemical toxins, including ethylene glycol (antifreeze), formaldehyde, phenol (carbolic acid) and even antibiotics like Neomycin and streptomycin.
In addition to the viruses and other additives, many vaccines also contain immune adjuvants like aluminum and squalene.
The purpose of an immune adjuvant added to a vaccine is to enhance (turbo charge) your immune response to the vaccination. Adjuvants cause your immune system to overreact to the introduction of the organism you’re being vaccinated against.
Adjuvants are supposed to get the job done faster (but certainly not more safely), which reduces the amount of vaccine required per dose, and the number of doses given per individual.
Less vaccine required per person means more individual doses available for mass vaccination campaigns. Coincidentally, this is exactly the goal of government and the pharmaceutical companies who stand to make millions from their vaccines.
Will There Be Immune Adjuvants in Swine Flu Vaccines?
The U.S. government has contracts with several drug companies to develop and produce swine flu vaccines. At least two of those companies, Novartis and GlaxoSmithKline, are using an adjuvant in their H1N1 vaccines.
The adjuvant? Squalene.
According to Meryl Nass, M.D., an authority on the anthrax vaccine,
“A novel feature of the two H1N1 vaccines being developed by companies Novartis and GlaxoSmithKline is the addition of squalene-containing adjuvants to boost immunogenicity and dramatically reduce the amount of viral antigen needed. This translates to much faster production of desired vaccine quantities.”[v]
Novartis’s proprietary squalene adjuvant for their H1N1 vaccine is MF59. Glaxo’s is ASO3. MF59 has yet to be approved by the FDA for use in any U.S. vaccine, despite its history of use in other countries.
Per Dr. Nass, there are only three vaccines in existence using an approved squalene adjuvant. None of the three are approved for use in the U.S.
And as if Vaccines Weren’t Dangerous Enough on Their Own …
… imagine them turbocharged.
The main ingredient in a vaccine is either killed viruses or live ones that have been attenuated (weakened and made less harmful).
Flu vaccines can also contain a number of chemical toxins, including ethylene glycol (antifreeze), formaldehyde, phenol (carbolic acid) and even antibiotics like Neomycin and streptomycin.
In addition to the viruses and other additives, many vaccines also contain immune adjuvants like aluminum and squalene.
The purpose of an immune adjuvant added to a vaccine is to enhance (turbo charge) your immune response to the vaccination. Adjuvants cause your immune system to overreact to the introduction of the organism you’re being vaccinated against.
Adjuvants are supposed to get the job done faster (but certainly not more safely), which reduces the amount of vaccine required per dose, and the number of doses given per individual.
Less vaccine required per person means more individual doses available for mass vaccination campaigns. Coincidentally, this is exactly the goal of government and the pharmaceutical companies who stand to make millions from their vaccines.
Will There Be Immune Adjuvants in Swine Flu Vaccines?
The U.S. government has contracts with several drug companies to develop and produce swine flu vaccines. At least two of those companies, Novartis and GlaxoSmithKline, are using an adjuvant in their H1N1 vaccines.
The adjuvant? Squalene.
According to Meryl Nass, M.D., an authority on the anthrax vaccine,
“A novel feature of the two H1N1 vaccines being developed by companies Novartis and GlaxoSmithKline is the addition of squalene-containing adjuvants to boost immunogenicity and dramatically reduce the amount of viral antigen needed. This translates to much faster production of desired vaccine quantities.”[v]
Novartis’s proprietary squalene adjuvant for their H1N1 vaccine is MF59. Glaxo’s is ASO3. MF59 has yet to be approved by the FDA for use in any U.S. vaccine, despite its history of use in other countries.
Per Dr. Nass, there are only three vaccines in existence using an approved squalene adjuvant. None of the three are approved for use in the U.S.
Subscribe to:
Posts (Atom)